Search - tctmd.com

Displaying 101 - 120 of 391

Sort: Relevancy | Date

RNA-Interference Agent Zilebesiran Looks Promising for BP-Lowering KARDIA-1

News Conference News AHA 2023

RNA-Interference Agent Zilebesiran Looks Promising for BP: KARDIA-1

Caitlin E. Cox

November 11, 2023

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Conference News TCT 2023

RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months

Todd Neale

October 31, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

News Daily News

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

Michael O'Riordan

September 08, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Daily News

Polypills Added to List of WHO’s Essential Medicines

Michael O'Riordan

August 02, 2023

News Daily News

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Michael O'Riordan

July 24, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Daily News

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Michael O'Riordan

June 19, 2023

News Opinion CV Team Dispatch

June 2023 News Roundup

L.A. McKeown

June 01, 2023

News Conference News EuroPCR 2023

Renal Denervation: Exploring Its Potential Beyond Hypertension

Todd Neale

May 18, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Opinion CV Team Dispatch

May 2023 News Roundup

L.A. McKeown

May 01, 2023

News Daily News

Low-Dose Polypills Top Other Approaches for Initial BP Control: Meta-analysis

Todd Neale

April 26, 2023

News Daily News

Drugs to Tweak RAAS Response No Help in Acute COVID-19, RCTs Show

Caitlin E. Cox

April 19, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows

L.A. McKeown

April 12, 2023

Advertisement

RNA-Interference Agent Zilebesiran Looks Promising for BP: KARDIA-1

November 2023 News Roundup

RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

September 2023 News Roundup

Polypills Added to List of WHO’s Essential Medicines

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

June 2023 News Roundup

Renal Denervation: Exploring Its Potential Beyond Hypertension

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

May 2023 News Roundup

Low-Dose Polypills Top Other Approaches for Initial BP Control: Meta-analysis

Drugs to Tweak RAAS Response No Help in Acute COVID-19, RCTs Show

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content